← Back to Intel
Insider ActivityPTGX
MOLINA ARTURO MD, Chief Medical Officer at Protagonist Therapeutics, Inc, sold $1.6M of PTGX
Updated Jun 14, 2026
MOLINA ARTURO MD
Chief Medical Officer
Protagonist Therapeutics, Inc ·
$PTGX
Transaction Details
| Insider | MOLINA ARTURO MD |
|---|---|
| Title | Chief Medical Officer |
| Company | Protagonist Therapeutics, Inc |
| Ticker | PTGX |
| Transaction Type | Sale |
| Transaction Date | 2026-03-26 |
| Shares Traded | 15,000 |
| Price Per Share | $104.79 |
| Total Value | $1.6M |
| Filed Date | 2026-03-27 |
| Accession Number | 0001104659-26-036319 |
Ownership Context
| Shares Owned After Transaction | 84,115 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001104659-26-036319
Other Insider Trades — PTGX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Waddill William D. | Director | sold | $969K | 2026-06-10 |
| Waddill William D. | Director | traded | $35K | 2026-06-10 |
| Waddill William D. | Director | traded | $99K | 2026-06-10 |
| Waddill William D. | Director | sold | $897K | 2026-05-29 |
| Waddill William D. | Director | traded | $106K | 2026-05-29 |
| PATEL DINESH V PH D | President and CEO, Director | sold | $7.5M | 2026-05-12 |
| PATEL DINESH V PH D | President and CEO, Director | traded | $1.6M | 2026-05-12 |
| PATEL DINESH V PH D | President and CEO, Director | sold | $7.5M | 2026-05-12 |
| PATEL DINESH V PH D | President and CEO, Director | traded | $1.6M | 2026-05-12 |
| Giraudo Bryan | Director | sold | $513K | 2026-05-08 |
Other Trades by MOLINA ARTURO MD
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | traded | $121K | 2026-03-26 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for PTGX — Protagonist Therapeutics, Inc →
Track PTGX insider activity in real time on The Wire →
Get alerts when MOLINA ARTURO MD files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:21 UTC